Intestinal pseudo-obstruction caused by diltiazem in a neutropenic patient

Annals of Pharmacotherapy

Volumn 39, Issue 10, 2005, Pages 1749-1751

  Young, Rebecca P ^a   Wu, Helen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diltiazem; Intestinal pseudo obstruction; Neutropenia

Indexed keywords

ALLOPURINOL; AMIODARONE; ATORVASTATIN; CALCIUM CHANNEL BLOCKING AGENT; CEFEPIME; CHLOROTHIAZIDE; COTRIMOXAZOLE; CYTARABINE; DILTIAZEM; FLUCONAZOLE; FLUTICASONE PROPIONATE PLUS SALMETEROL; IDARUBICIN; LINEZOLID; MEROPENEM; MOXIFLOXACIN; SPIRONOLACTONE; TOBRAMYCIN; VANCOMYCIN; VORICONAZOLE;

ABDOMINAL DISTENSION; ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; INFECTION; INJURY; INTESTINE PSEUDOOBSTRUCTION; MALE; NEPHROTOXICITY; NEUTROPENIA; NEUTROPENIC ENTEROCOLITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROBABILITY; RADIOGRAPHY; SIDE EFFECT;

AGED; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; MALE; NEUTROPENIA;

EID: 25844485511     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G133     Document Type: Article

References (18)

1. Delgado-Aros S. Pseudo-obstruction in the critically ill. Best Pract Res Clin Gastroenterol 2003;17:427-44.
2. Kamm M. Intestinal pseudo-obstruction. Gut 2000;47(suppl IV):iv84.
3. Neitlich JD, Burrell MI. Drug-induced disorders of the colon. Abdom Imaging 1999;24:23-8.
4. Fauville JP, Hantson R Honore P, Belpaire F, Rosseel MT, Mahieu P. Severe diltiazem poisoning with intestinal pseudo-obstruction: case report and toxicological data. J Toxicol Clin Toxicol 1995;33:273-7.
5. Mantzoros CS, Prabhu AS, Sowers JR. Paralytic ileus as a result of diltiazem treatment. J Intern Med 1994;235:613-4.
6. Lamaison D, Abrieu V, Fialip J, Dumas R, Androikoff M, Lavarenne J. Acute intestinal occlusion and calcium antagonists. Therapie 1989;44:201-2.
7. Quezado Z, Lippmann M. Wertheimer J. Severe cardiac, respiratory and metabolic complications of massive verapamil overdose. Crit Care Med 1991;19:436-8.
8. Schultz HS, Vernon B. Intestinal pseudo-obstruction related to using verapamil. West J Med 1989;151:556-8.
9. Fahy BG. Pseudoobstruction of the colon: early recognition and therapy. Neurosurg Anesthesiol 1996;8:133-6.
10. Hund E, Aschoff A, Tronnier V, Hampl J, Kunze S. Nimodipine: evidence for clinically significant gastrointestinal side-effect. Acta Neurochir (Wien) 1990;102:73-5.
11. Awouters F, Megens A, Verlinden M, Schuurkes J, Niemegeers C, Hanssen PAJ. Loperamide survey of studies on mechanism of its antidiarrheal activity. Dig Dis Sci 1993;38:977-95.
12. Peterson DE, Cariello A. Mucosal damage: a major risk factor for severe complications after cytotoxic therapy. Semin Oncol 2004;31(3 suppl 8):35-44.
13. Gorschluter M, Glasmacher A, Hahn C, Leutner C, Marklein G, Remig J, et al. Severe abdominal infections in neutropenic patients. Cancer Invest 2001;19:669-77.
14. Quigley M, Bethel K, Nowacki M, Millard F, Sharpe R. Neutropenic enterocoloitis: a rare presenting complication of acute leukemia. Am J Hematol 2001;66:213-9.
15. Prescribing information. Nimotop: www.nimotopusa.com/prescribing/index. html (accessed 2005 May 1).
16. Chaffman M, Brogden RN. Diltiazem: a review of its pharmacological properties and therapeutic efficacy. Drugs 1985;29:387-454.
17. Katz AM. Molecular basis of calcium channel blockade. Am J Cardiol 1992;69:17E-22E.
18. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.